GAO Report: While Hard to Measure, Progress in FDA’s Overseas Inspections Still Hurt by Job Vacancies

Drug Industry Daily
The FDA has made great strides in conducting international inspections — but still remains detrimentally understaffed, according to the government’s official watchdog, during a time when the agency has begun to inspect more sites overseas than within the U.S.

To View This Article:


Subscribe To Drug Industry Daily